Karyopharm Therapeutics Inc
NASDAQ:KPTI
Karyopharm Therapeutics Inc
Cash from Investing Activities
Karyopharm Therapeutics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
Cash from Investing Activities
$62.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$11.1B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-80%
|
CAGR 10-Years
-23%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$3.6B
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-84%
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$27.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.4B
|
CAGR 3-Years
-705%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
-57%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$4.6B
|
CAGR 3-Years
-89%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-26%
|
See Also
What is Karyopharm Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
62.3m
USD
Based on the financial report for Mar 31, 2024, Karyopharm Therapeutics Inc's Cash from Investing Activities amounts to 62.3m USD.
What is Karyopharm Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
20%
The average annual Cash from Investing Activities growth rates for Karyopharm Therapeutics Inc have been 20% over the past three years .